Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC) -- Ignore unavailable to you. Want to Upgrade?

To: former_pgs who wrote (620)	3/17/2005 10:47:08 AM
From: Sam Citron	Read Replies (1) \| Respond to of 946

they got their money back, but shareholders didn't Well, Max Link may be no Lindsay Rosenwald, buy I'm not sure I would be overly cynical in assessing his motives. Since he is not an officer, I wouldn't think he normally gets any bonuses. Any compensation he receives has to be disclosed in the proxy. Let's see how it plays out. Here's an article which suggests that the investor should ask which insider is buying. moneycentral.msn.com Sam

To: former_pgs who wrote (620)	3/17/2005 11:03:46 AM
From: Icebrg	Read Replies (3) \| Respond to of 946

Ex-pgs, I wonder if it is correct to refer to CTIC as " a Rosenwald" company. True, Rosenwald owns some 5 % of the capital in the company. But as far as I have seen, he has not any board representation directly or through a representative. So, probably his influence is limited to nonexistent. He was not involved in the founding of the company. His shares go back to the transaction where CTIC bought PolaRx (the company owning Trisenox). We have had another 4A reported btw. John Fluke (!) has doubled his holding from 5.000 to 10.000 shares. The 5.000 shares were bought at 4 dollars. Erik